GRI
GRI
NASDAQ · Biotechnology

Gri Bio Inc

$2.28
-0.02 (-0.87%)
As of Mar 29, 11:04 PM ET ·
Analyst Consensus
Strong Buy
6
Analysts
Moderate
Coverage
Buy 5 83%
Hold 1 17%
Sell 0 0%
Price Target
Analyst Price Target +1,627.6% upside
Low Target $26.66
Average Target $39.39
High Target $54.88
Current Price $2.28
Current
$2.28
Target
$39.39
$26.66 $39.39 avg $54.88
Scenario Analysis
Bear Case
$26.66
1,069.3%
Low target
Base Case
$39.39
+1,627.6%
Avg target
Bull Case
$54.88
+2,307.0%
High target
Risk/Reward
2.2x
Favorable
Price in Context
Target vs 52W High
$39.39
-87.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +18.4%
AMGN
Amgen Inc
Hold 42 50% $190.87 -45.8%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +160.2%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -1.8%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -69.1%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -12.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -28.5%